FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137883989> ?p ?o ?g. }

• W3137883989 endingPage "1550" @default.
• W3137883989 startingPage "1535" @default.
• W3137883989 abstract "Phosphodiesterase 5 inhibitor (PDE5i) treatment is associated with reduced mortality compared with no treatment for erectile dysfunction after myocardial infarction (MI).This study sought to investigate the association between treatment with PDE5i or alprostadil and outcomes in men with stable coronary artery disease.All Swedish men with a prior MI or revascularization who received PDE5i or alprostadil during 2006 through 2013 at >6 months after the event were included, using the Swedish Patient Register and the Swedish Prescribed Drug Register. Cox regression was used to estimate adjusted hazard ratios with 95% confidence intervals for all-cause mortality, MI, heart failure, cardiovascular mortality, noncardiovascular mortality, cardiac revascularization, peripheral arterial disease, and stroke in men treated with PDE5i versus alprostadil.This study included 16,548 men treated with PDE5i and 1,994 treated with alprostadil. The mean follow-up was 5.8 years, with 2,261 deaths (14%) in the PDE5i group and 521 (26%) in the alprostadil group. PDE5i compared with alprostadil treatment was associated with lower mortality (hazard ratio: 0.88; 95% confidence interval: 0.79 to 0.98) and with similar associations for MI, heart failure, cardiovascular mortality, and revascularization. When quintiles (q) of filled PDE5i prescriptions were compared using q1 as reference, patients in q3, q4, and q5 had lower all-cause mortality. Among alprostadil users, those in q5 had a lower all-cause mortality compared to q1.In men with stable coronary artery disease, treatment with PDE5i is associated with lower risks of death, MI, heart failure, and revascularization compared with alprostadil treatment. Although the decrease in all-cause mortality was PDE5i dose dependent, the data do not permit the inference of causality or any clinical benefits of PDE5i because of the observational study design." @default.
• W3137883989 created "2021-03-29" @default.
• W3137883989 creator A5000020478 @default.
• W3137883989 creator A5022613340 @default.
• W3137883989 creator A5027129922 @default.
• W3137883989 creator A5034103933 @default.
• W3137883989 creator A5076590891 @default.
• W3137883989 creator A5078072462 @default.
• W3137883989 creator A5083132541 @default.
• W3137883989 date "2021-03-01" @default.
• W3137883989 modified "2023-10-09" @default.
• W3137883989 title "Association of Phosphodiesterase-5 Inhibitors Versus Alprostadil With Survival in Men With Coronary Artery Disease" @default.
• W3137883989 cites W1219578225 @default.
• W3137883989 cites W1675703737 @default.
• W3137883989 cites W1968494724 @default.
• W3137883989 cites W1977881213 @default.
• W3137883989 cites W197868875 @default.
• W3137883989 cites W2031027703 @default.
• W3137883989 cites W2052641595 @default.
• W3137883989 cites W2063167222 @default.
• W3137883989 cites W2070207766 @default.
• W3137883989 cites W2082371629 @default.
• W3137883989 cites W2111494287 @default.
• W3137883989 cites W2114647023 @default.
• W3137883989 cites W2126049444 @default.
• W3137883989 cites W2152303912 @default.
• W3137883989 cites W2166018731 @default.
• W3137883989 cites W2168021466 @default.
• W3137883989 cites W2168458505 @default.
• W3137883989 cites W2344962666 @default.
• W3137883989 cites W2498004564 @default.
• W3137883989 cites W2500951909 @default.
• W3137883989 cites W2594366141 @default.
• W3137883989 cites W2725108908 @default.
• W3137883989 cites W2756691777 @default.
• W3137883989 doi "https://doi.org/10.1016/j.jacc.2021.01.045" @default.
• W3137883989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33766260" @default.
• W3137883989 hasPublicationYear "2021" @default.
• W3137883989 type Work @default.
• W3137883989 sameAs 3137883989 @default.
• W3137883989 citedByCount "16" @default.
• W3137883989 countsByYear W31378839892021 @default.
• W3137883989 countsByYear W31378839892022 @default.
• W3137883989 countsByYear W31378839892023 @default.
• W3137883989 crossrefType "journal-article" @default.
• W3137883989 hasAuthorship W3137883989A5000020478 @default.
• W3137883989 hasAuthorship W3137883989A5022613340 @default.
• W3137883989 hasAuthorship W3137883989A5027129922 @default.
• W3137883989 hasAuthorship W3137883989A5034103933 @default.
• W3137883989 hasAuthorship W3137883989A5076590891 @default.
• W3137883989 hasAuthorship W3137883989A5078072462 @default.
• W3137883989 hasAuthorship W3137883989A5083132541 @default.
• W3137883989 hasBestOaLocation W31378839891 @default.
• W3137883989 hasConcept C126322002 @default.
• W3137883989 hasConcept C127413603 @default.
• W3137883989 hasConcept C164705383 @default.
• W3137883989 hasConcept C207103383 @default.
• W3137883989 hasConcept C2778198053 @default.
• W3137883989 hasConcept C2778213512 @default.
• W3137883989 hasConcept C2779464278 @default.
• W3137883989 hasConcept C2779929075 @default.
• W3137883989 hasConcept C2780645631 @default.
• W3137883989 hasConcept C44249647 @default.
• W3137883989 hasConcept C500558357 @default.
• W3137883989 hasConcept C50382708 @default.
• W3137883989 hasConcept C71924100 @default.
• W3137883989 hasConcept C78519656 @default.
• W3137883989 hasConceptScore W3137883989C126322002 @default.
• W3137883989 hasConceptScore W3137883989C127413603 @default.
• W3137883989 hasConceptScore W3137883989C164705383 @default.
• W3137883989 hasConceptScore W3137883989C207103383 @default.
• W3137883989 hasConceptScore W3137883989C2778198053 @default.
• W3137883989 hasConceptScore W3137883989C2778213512 @default.
• W3137883989 hasConceptScore W3137883989C2779464278 @default.
• W3137883989 hasConceptScore W3137883989C2779929075 @default.
• W3137883989 hasConceptScore W3137883989C2780645631 @default.
• W3137883989 hasConceptScore W3137883989C44249647 @default.
• W3137883989 hasConceptScore W3137883989C500558357 @default.
• W3137883989 hasConceptScore W3137883989C50382708 @default.
• W3137883989 hasConceptScore W3137883989C71924100 @default.
• W3137883989 hasConceptScore W3137883989C78519656 @default.
• W3137883989 hasFunder F4320322169 @default.
• W3137883989 hasFunder F4320322315 @default.
• W3137883989 hasFunder F4320322570 @default.
• W3137883989 hasIssue "12" @default.
• W3137883989 hasLocation W31378839891 @default.
• W3137883989 hasLocation W31378839892 @default.
• W3137883989 hasOpenAccess W3137883989 @default.
• W3137883989 hasPrimaryLocation W31378839891 @default.
• W3137883989 hasRelatedWork W1540632834 @default.
• W3137883989 hasRelatedWork W1561682977 @default.
• W3137883989 hasRelatedWork W1966389829 @default.
• W3137883989 hasRelatedWork W1992686616 @default.
• W3137883989 hasRelatedWork W2994686985 @default.
• W3137883989 hasRelatedWork W4205845705 @default.
• W3137883989 hasRelatedWork W4281722959 @default.
• W3137883989 hasRelatedWork W4361755853 @default.
• W3137883989 hasRelatedWork W4379796428 @default.

• next